TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats
Background: Current diabetes therapies often fail to address the loss of insulin-producing β-cells. Bone marrow mesenchymal stem cells (BMSCs) can differentiate into insulin-producing cells (IPCs), but functional maturity remains limited. Toll-like receptor 9 (TLR9) agonists may enhance BMSC maturat...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
University of Karachi
2026-01-01
|
| Seri Bilgileri: | Pakistan Journal of Pharmaceutical Sciences |
| Online Erişim: | https://pjps.pk/single-article?id=cmr8j09b1007k85f4lfu448r9 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|